What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Stochastic Oscillator

Score

-0.2

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 39 9.2 0.41% 0.62% 19.7% -4.1% 207.3%
SHORT 40 11.3 0.38% 0.58% 4.7% -4.8% -53.6%

Summary

Technical Analysis


In technical analysis of securities trading the stochastic oscillator is a momentum indicator that uses support and resistance levels. Dr George Lane developed this indicator in the late 1950s. The term stochastic refers to the point of a current price in relation to its price range over a period of time. This method attempts to predict price turning points by comparing the closing price of a security to its price range.

Calculation: Stochastic Oscillator:
1) %K = (Current Close - Lowest Low)/(Highest High - Lowest Low) * 100;
2) %D = 3-day SMA of %K Lowest Low = lowest low for the look-back period Highest High = highest high for the look-back period %K is multiplied by 100 to move the decimal point two places;


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Stochastic Oscillator

Download
Company Close Change(%) Volume Value Signal
AGG Anglogold Ashanti 5.72 2.3 9,100 19.6 BEARISH
CEN Central Australian Phosphate 6.75 1.7 6,905 20 BEARISH
FLN Freelancer 0.65 1.6 54,438 8.3 BEARISH
MNF My Net Fone 5 1.6 81,154 19.2 BEARISH
JIN Jin 20.31 1.3 224,143 11.9 BEARISH
DXS Dexus Property 11.63 1.2 3,006,175 19.4 BEARISH
CDD Cardno 0.49 1 119,301 8.3 BEARISH
AZJ Aurizon Holdings 5.77 0.9 4,694,231 18.4 BEARISH
FLT Flight Centre 40.06 0.9 364,109 17.7 BEARISH
NEA Nearmap 2.48 0.8 2,548,416 14.5 BEARISH